PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1186
https://www.valueinhealthjournal.com/article/S1098-3015(12)01251-X/fulltext
Title : PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01251-X&doi=10.1016/j.jval.2012.03.1186
First page : A220
Section Title : Cancer
Open access? : No
Section Order : 711
Categories :
Tags :
Regions :
ViH Article Tags :